ClearanceBrief
Recall Z-1105-2023 ยท QLT Covid-19 Multi-Analyte Respiratory Panel Nucleic Acid Devices

Roche Molecular Systems, Inc.

cobas SARS-CoV-2 & Influenza A/B Qualitative nucleic acid test for use on the cobas 5800/6800/8800 Systems; Material Number 09446125190

DateFeb 7, 2023 (initiated Dec 21, 2022)
StatusOpen, Classified
ReasonThe firm received customer complaints regarding false negative Influenza A (Flu A) results and late Flu A Target Ct values. A false negative influenza A result may lead to additional testing, psychological distress, and delays to targeted therapy for influenza as well as true diagnosis.
Root causeDevice Design
ActionOn December 22, 2022, Roche posted the Urgent Medical Device Correction (UMDC) to its website (dialog.roche.com). On December 27, 2022, the firm also sent UMDC letters to affected customers. Consignees were instructed to monitor for negative influenza A results that are inconsistent with clinical presentation and/or other clinical and epidemiological information. Authorized or licensed Influenza NAATs are available for confirmation if clinically indicated for at-risk patients. Additionally, consignees are reminded to review the tests Instructions for Use, specifically the Intended Use State
Quantity9,948 OUS only
DistributionDomestic distribution nationwide. Foreign distribution worldwide.
FDA recordOpen on fda.gov

510(k) clearances named in this recall

This recall record lists no 510(k) number.